Abstract
Jaundice is one of the most common situations during the neonatal period. Alloimmune haemolytic disease of the fetus and newborn (AHDFN) is a major cause of pathological jaundice during the neonatal period. Since the establishment of anti-D prophylaxis, other antigens have gained greater clinical importance. The maternal antierythrocyte antibody screen is of great importance in monitoring pregnancy and in predicting the risk of AHDFN. A positive result should alert to the possibility of AHDFN and promote close surveillance of fetal anaemia, as well as neonatal anaemia and hyperbilirubinaemia. We describe a case of AHDFN due to incompatibility of the Rhesus c (Rhc) subgroup, diagnosed in pregnancy, but without effective transmission of information in the perinatal period, so a positive maternal antierythrocyte antibody screen was missed. This case highlights the importance of non-RhD antigens in this disease, but also the importance of a successful handoff of information in the delivery room.
Reference20 articles.
1. Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation
2. Hyperbilirubinemia
3. Improving the management and outcome in haemolytic disease of the foetus and newborn;Lopriore;Blood Transfus,2013
4. Hemolytic disease of the fetus and newborn: managing the mother, fetus, and newborn
5. Dean L . Blood groups and red cell antigens. Bethesda, MD: NCBI, 2005. www.ncbi.nlm.nih.gov/books/NBK2261/pdf/Bookshelf_NBK2261.pdf
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献